The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R01 Clinical Trial Not Allowed)
The purpose of this Funding Opportunity Announcement (FOA) is to support research which can elucidate mechanism(s) of action by which gut microbes inhibit or enhance anti-tumor immune responses. Thus, research projects should be focused on delineating how specific microbes or their metabolites target host immune responses to prevent colitis-associated or sporadic tumor formation.
This FOA runs in parallel with an FOA of identical scientific scope, PAR-19-199, which utilizes the Exploratory/Developmental Grant (R21) mechanism.
- Letter of Intent Due Date(s): 30 days prior to the application due date
- Application Due Date(s): June 10, 2019; November 6, 2019; June 10, 2020; November 6 2020; June 10, 2021; November 8, 2021
PAR-19-198 Expiration Date November 9, 2021